Advertisement

Topics

BioSyent Inc RX Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

00:05 EST 25 Feb 2017 | BioPortfolio Reports

Summary

BioSyent Inc BioSyent, formerly Hedley Technologies Inc., concentrates on the acquisition and inlicensing of products, and marketing of technologies to enhance human health. Its products include Aguettant System for prefilled syringes; Cathejell Jelly; FeraMAX 150, an oral hematinic; FeraMAX powder, a water soluble oral iron supplement; RepaGyn, a vaginal suppository; ProktisM, and ProtectIt, is a nonchemical which is used as a preventative treatment against insect infestations in stored grains. BioSyent's products are used for surface anesthesia and lubrication for various procedures that includes cystoscopies and other endourethral operations; prevention of iron deficiency anaemia, and treatment of vaginal mucosa and vaginal dryness, among others. The company distributes its products to pharmacies and hospitals across Canada. It also operates through its subsidiary in the US. BioSyent is headquartered in Toronto, Ontario, Canada.

BioSyent Inc Key Recent Developments

Nov 23, 2016: BioSyent Releases Results for Third Quarter and First Nine Months of 2016
Aug 12, 2016: BioSyent Releases Q2 and H1 2016 Results
May 27, 2016: BioSyent Releases Q1 2016 Results
May 25, 2016: BioSyent Signs Exclusive Distribution Agreement for Two New Cardiovascular Products
Mar 04, 2016: BioSyent Releases Q4 and Full Year 2015 Results

This comprehensive SWOT profile of BioSyent Inc provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BioSyent Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*, x000D
x000D
Business description A detailed description of the company's operations and business divisions.x000D
Corporate strategy Analyst's summarization of the company's business strategy.x000D
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.x000D
Company history Progression of key events associated with the company.x000D
Major products and services A list of major products, services and brands of the company.x000D
Key competitors A list of key competitors to the company.x000D
Key employees A list of the key executives of the company.x000D
Executive biographies A brief summary of the executives' employment history.x000D
Key operational heads A list of personnel heading key departments/functions.x000D
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.x000D
Key manufacturing facilities A list of key manufacturing facilities of the company.x000D
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.x000D
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.x000D
x000D
Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,x000D
x000D
You get detailed information about the company and its operations to identify potential customers and suppliers.x000D
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.x000D
x000D
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.x000D
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. x000D
x000D
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.x000D
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.x000D
x000D
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.x000D
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.x000D
x000D
Gain key insights into the company for academic or business research.x000D
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: BioSyent Inc RX Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

NEXT ARTICLE

More From BioPortfolio on "BioSyent Inc RX Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Anesthesia
Anesthesia is the loss of feeling or sensation in all or part of the body. It may result from damage to nerves or can be induced by an anesthetist (a medical professional) using anesthetics such as thiopental or propofol or sevoflurane during a surgical ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...